Nj State Employees Deferred Compensation Plan Pacific Biosciences Of California, Inc. Transaction History
Nj State Employees Deferred Compensation Plan
- $824 Million
- Q3 2024
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 100,000 shares of PACB stock, worth $160,000. This represents 0.02% of its overall portfolio holdings.
Number of Shares
100,000
Previous 100,000
-0.0%
Holding current value
$160,000
Previous $137,000
24.09%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding PACB
# of Institutions
253Shares Held
228MCall Options Held
745KPut Options Held
1.23M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.4MShares$53.5 Million0.54% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$37.8 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$37.4 Million6.35% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V820.3MShares$32.5 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$28.2 Million0.0% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $360M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...